Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningBone MarrowHematopoietic Stem Cell MobilizationHematologic NeoplasmsBone Marrow CellsWhole-Body IrradiationGraft SurvivalGranulocyte Colony-Stimulating FactorStem Cell TransplantationBusulfanTransplantation ChimeraLeukapheresisCyclophosphamideTissue DonorsCombined Modality TherapyLeukemiaHematopoietic Stem CellsAnemia, AplasticAntigens, CD34RecurrenceMelphalanHistocompatibility TestingHistocompatibilityTreatment OutcomeRemission InductionBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation, IsogeneicMultiple MyelomaLymphoma, Non-HodgkinStem CellsLeukemia, Myeloid, AcuteImmunosuppressive AgentsHematopoiesisCord Blood Stem Cell TransplantationGraft vs Leukemia EffectBone Marrow PurgingMyeloablative AgonistsEtoposideLymphocyte DepletionLiver TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsLeukocyte TransfusionRetrospective StudiesGraft vs Tumor EffectSurvival AnalysisDisease-Free SurvivalMyelodysplastic SyndromesInfectionCytarabineSurvival RateImmunosuppressionBone and BonesAcute DiseaseAntineoplastic Agents, AlkylatingT-LymphocytesCytomegalovirus InfectionsCyclosporineBone Marrow DiseasesLymphocyte TransfusionBlood CellsHLA AntigensTransplantation ImmunologyHematologic DiseasesThiotepaLeukemia, MyeloidSalvage TherapyHepatic Veno-Occlusive DiseaseRadiation ChimeraFatal OutcomeNuclear FamilyCarmustineMice, Inbred C57BLLymphomaKidney TransplantationFollow-Up StudiesHodgkin DiseaseGraft vs Host ReactionGraft RejectionLeukocyte CountVidarabineBlood Cell CountImmunophenotypingVincristinePlatelet CountPOEMS SyndromeChimeraFlow CytometryHistiocytosis, Non-Langerhans-CellColony-Forming Units AssayNeoplasm, ResidualAntigens, CD